Back

Importation models for travel-related SARS-CoV-2 cases reported in Newfoundland and Labrador during the COVID-19 pandemic

Mohammadi, Z.; Cojocaru, M. G.; Arino, J.; Hurford, A.

2023-06-12 public and global health
10.1101/2023.06.08.23291136
Show abstract

During the COVID-19 pandemic the World Health Organization updated guidelines for travel measure implementation to recommend consideration of a regions specific epidemiological, health system, and socioeconomic context. As such, travel measure implementation decisions require region-specific data, analysis, and models to support risk assessment frameworks. From May 2020 to May 2021, the Canadian province of Newfoundland and Labrador (NL) implemented travel measures that required self-isolation and testing of individuals returning from out-of-province travel. We found that during the pandemic travel to NL decreased by 82%. Our best model was 135 times more likely to explain reported travel-related cases arriving in NL than a model where travel volume and infection data did not consider the Canadian jurisdiction of origin. To test an approach used in other studies, we formulated a model without considering the travel-related case data and found that this model performed very poorly. We conclude that importation models need to be supported with data describing the daily number of travel-related cases arriving in Canadian jurisdictions and daily travel volumes originating from each country and each Canadian province and territory. While there was some reporting of this information during the COVID-19 pandemic, these data were not consistently reported or easily accessible.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
BMC Public Health
based on 148 papers
Top 0.4%
12.6%
2
PLOS ONE
based on 1737 papers
Top 47%
11.0%
3
CMAJ Open
based on 12 papers
Top 0.1%
10.1%
4
JMIR Public Health and Surveillance
based on 45 papers
Top 0.9%
4.5%
5
Frontiers in Public Health
based on 135 papers
Top 7%
4.5%
6
BMC Infectious Diseases
based on 110 papers
Top 3%
2.8%
7
Scientific Reports
based on 701 papers
Top 56%
2.8%
8
BMJ Open
based on 553 papers
Top 35%
2.4%
50% of probability mass above
9
Vaccine
based on 140 papers
Top 3%
2.4%
10
Canadian Medical Association Journal
based on 15 papers
Top 0.2%
2.3%
11
International Journal of Infectious Diseases
based on 115 papers
Top 7%
2.3%
12
Eurosurveillance
based on 77 papers
Top 4%
1.8%
13
Journal of Travel Medicine
based on 17 papers
Top 0.6%
1.6%
14
Epidemics
based on 96 papers
Top 5%
1.6%
15
Disaster Medicine and Public Health Preparedness
based on 16 papers
Top 3%
1.3%
16
PLOS Global Public Health
based on 287 papers
Top 18%
1.2%
17
Public Health
based on 34 papers
Top 5%
1.2%
18
Annals of Internal Medicine
based on 27 papers
Top 1%
1.2%
19
Emerging Infectious Diseases
based on 84 papers
Top 9%
1.2%
20
The Lancet Regional Health - Americas
based on 20 papers
Top 0.6%
1.2%
21
JAMA Network Open
based on 125 papers
Top 15%
1.2%
22
Preventive Medicine
based on 11 papers
Top 0.4%
0.8%
23
The Lancet Public Health
based on 20 papers
Top 2%
0.8%
24
The Lancet Infectious Diseases
based on 57 papers
Top 7%
0.8%
25
Epidemiology and Infection
based on 80 papers
Top 13%
0.7%
26
F1000Research
based on 28 papers
Top 6%
0.7%
27
Clinical Infectious Diseases
based on 219 papers
Top 22%
0.7%
28
The American Journal of Tropical Medicine and Hygiene
based on 50 papers
Top 11%
0.7%
29
Royal Society Open Science
based on 49 papers
Top 6%
0.7%